Clinical trial · Observational
Non-interventional Study With Nab-Paclitaxel (Abraxane®)
Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer
NCT01689610CI-TRIAL-00033376NABUCCOcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this non-interventional study is to collect data on the efficacy and safety of Nab-Paclitaxel in the routine application.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Adult female patients with MBC
- description
- This is an observational study, no interventions are specified
Primary outcomes (1)
- measure
- Time to Tumor Progression (TTP)
- timeFrame
- 6 months after last-patient-in (LPI)
Secondary outcomes (12)
- measure
- Overall Response Rate (ORR)
- timeFrame
- 6 months after last-patient-in (LPI)
- measure
- Overall survival (OS)
- timeFrame
- 6 months after last-patient-in (LPI)
- measure
- Time to treatment discontinuation
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female Patients with metastatic breast cancer, who are at least 18 years old (no upper age limit) Exclusion Criteria: * Contraindication according to the summary of product characteristics of Abraxane® * No signed patient informed consent form available * pregnant or breastfeeding patients.
References
Publications (0)
Data not yet available
No reference posted for this study.